# Yingtai Medical to acquire at least 51% of Hangzhou Weiqiang Medical Technology

Yingtai Medical (01501) announced on December 18, 2024, that it has signed an acquisition意向协议 to acquire at least a 51% controlling stake in Hangzhou Weiqiang Medical Technology through capital increase and share acquisition, with a planned capital increase of no less than RMB 200 million.

- Type: Acquisition
- Announced: 2024-12-18
- Where: Hangzhou, China
- Value: $28.0M (200.0M CNY)
- Status: announced
- Products: aortic and peripheral vascular interventional medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Yingtai Medical](https://endata.com/companies/81837.md) (acquirer)
- [Hangzhou Weiqiang Medical Technology](https://endata.com/companies/81838.md) (target)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/1226592.html), 2024-12-18: "公司建议收购目标公司可进一步完善公司在主动脉及外周血管介入及植入领域的产品布局。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.